• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国卫生研究院文献>GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW >Retrospective analysis of a VACM (vacuum-assisted closure and mesh-mediated fascial traction) treatment manual for temporary abdominal wall closure – results of 58 consecutive patients
【2h】

Retrospective analysis of a VACM (vacuum-assisted closure and mesh-mediated fascial traction) treatment manual for temporary abdominal wall closure – results of 58 consecutive patients

机译：回顾性分析VACM（真空辅助闭合和网状筋膜牵引）治疗手册用于临时性腹壁闭合-连续58例患者的结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

>Introduction: The optimal treatment concept for temporary abdominal closure (TAC) in critically ill visceral surgery patients with open abdomen (OA) continues to be unclear. The VACM (vacuum-assisted closure and mesh-mediated fascial traction) therapy seems to permit higher delayed primary fascial closure rates (FCR) than other TAC procedures. >Material and methods: Patients of our clinic (n=58) who were treated by application of a VAC/VACM treatment manual in the period from 2005 to 2008 were retrospectively analysed. >Results: The overall FCR of all patients was 48.3% (95% confidence interval: 34.95–61.78). An FCR of 61.3% was achieved in patients who had a vicryl mesh implanted at the fascial level (VACM therapy) in the course of treatment. Mortality among patients treated with VACM therapy was 45.2% (95% CI: 27.32–63.97).>Conclusions: The results of our own study confirm the results of previous studies which showed an acceptable FCR among non-trauma patients who were treated with VACM therapy. VACM therapy currently appears to be the treatment regime of choice for patients with OA requiring TAC.
机译：>简介：对于重症内脏手术，开腹（OA）的临时腹部闭合（TAC）的最佳治疗方案仍然不清楚。 VACM（真空辅助闭合和网状介导的筋膜牵引）治疗似乎比其他TAC程序具有更高的延迟初级筋膜闭合率（FCR）。 >材料和方法：我们回顾性分析了我院2005年至2008年期间应用VAC / VACM治疗手册治疗的患者（n = 58）。 >结果：所有患者的总体FCR为48.3％（95％置信区间：34.95-61.78）。在治疗过程中以筋膜水平（VACM治疗）植入vicryl网格的患者的FCR为61.3％。接受VACM治疗的患者的死亡率为45.2％（95％CI：27.32–63.97）。>结论：我们自己的研究结果证实了以往研究的结果，该研究表明非创伤患者可接受的FCR使用VACM治疗的患者。对于需要TAC的OA患者，VACM治疗目前似乎是首选的治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号